Trial Profile
A phase I clinical trial to investigate the food effect on the pharmacokinetics of NVP-1402 in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Apr 2022
Price :
$35
*
At a glance
- Drugs NVP 1402 (Primary)
- Indications Behavioural disorders; CNS disorders; Dementia
- Focus Pharmacokinetics
- Sponsors Navipharm
- 16 May 2018 Status changed from active, no longer recruiting to completed.
- 06 Mar 2018 Planned End Date changed from 28 Feb 2018 to 30 Apr 2018.
- 20 Dec 2017 Status changed from not yet recruiting to active, no longer recruiting.